126 related articles for article (PubMed ID: 38451512)
1. PAR2 biased signaling on the move.
Nieman MT
Blood; 2024 Mar; 143(10):835-836. PubMed ID: 38451512
[No Abstract] [Full Text] [Related]
2. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
4. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
6. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.
Wu B; Zhou H; Hu L; Mu Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):837-46. PubMed ID: 23233043
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro.
Zhou F; Zhou H; Wang T; Mu Y; Wu B; Guo DL; Zhang XM; Wu Y
Acta Pharmacol Sin; 2012 Jan; 33(1):120-6. PubMed ID: 22101170
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
9. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
12. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex.
Benelhaj NE; Maraveyas A; Featherby S; Collier MEW; Johnson MJ; Ettelaie C
Thromb Res; 2019 Mar; 175():13-20. PubMed ID: 30677622
[TBL] [Abstract][Full Text] [Related]
13. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
Hoffman M; Monroe DM; Roberts HR
Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.
Zhang Q; Petersen HH; Ostergaard H; Ruf W; Olson AJ
Proteins; 2009 Nov; 77(3):559-69. PubMed ID: 19536895
[TBL] [Abstract][Full Text] [Related]
15. Binding of human factor VII and VIIa to monocytes.
Broze GJ
J Clin Invest; 1982 Sep; 70(3):526-35. PubMed ID: 6980899
[TBL] [Abstract][Full Text] [Related]
16. [Role of NF-κB in factor VIIa-induced proliferation and migration of colon cancer cell line SW620 cells].
Guo DL; Zhou H; Wu Y; Zhou F; Zhang XM; Xu GY; Wen HP
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):649-53. PubMed ID: 22340043
[TBL] [Abstract][Full Text] [Related]
17. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
18. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of the mechanisms of coagulation factor VIIa-induced colon cancer SW620 cell proliferation and migration].
Shi WX; Zhou H; Li N; Huang HL; Zhou BC
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):485-9. PubMed ID: 19950693
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
